“In 2023 we successfully executed our plan and achieved several key milestones that position Yield10 to build a sustainable products business based on engineered Camelina,” said Oliver Peoples, president and CEO of Yield10. “Our crop innovations are intended to support grower adoption of the crop and enable commercial-scale planting to produce Camelina oil and meal products targeting significant market opportunities.”
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on YTEN:
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
- Yield10 announces clearance of E3902 Camelina for planting in Canada
- Yield10 announces USDA-APHIS determined camelina can be grown, bred in U.S.
- Is YTEN a Buy, Before Earnings?
- Yield10 Bioscience reports on proprietary varieties of winter camilina